Acquisition of 100% Stake ⁤in Sonio, France: Innovating Medical Devices with AI Solutions

Samsung Medison has set out to secure ‘super-gap’ technology in medical⁣ devices, including ultrasound imaging, by combining medical⁢ devices and AI solutions through the acquisition of a French artificial intelligence ‍(AI) startup.

Samsung Medison announced that it ‍had completed the acquisition of 100% of the shares⁣ of French startup Sonio on the ‌30th of last ​month. Sonio is a startup that developed ultrasound diagnostic reporting and AI diagnostic assistance functions. Samsung Medison expects that through the acquisition of Sonio, it will be able to ⁢present solutions utilizing AI and information and communications technology (IT).

A Samsung Medison official emphasized, “We are focusing on simplifying the medical staff workflow and innovating the accessibility and accuracy​ of ​medical services,”‍ and “The acquisition of Sonio is a strategic decision to further strengthen this direction.” Samsung Medison plans to contribute to eliminating the medical ⁤gap by combining Sonio’s AI solutions with‌ Samsung technology.

Samsung Medison is pinning its hopes on the Sonio AI solution, Detect. Detect evaluates ultrasound ⁤image quality in real time. It automatically extracts and provides optimal ultrasound images, thereby increasing‍ the accuracy of ultrasound diagnosis and helping to alleviate the⁤ gap in medical staff ​capabilities.

“Sonio AI solutions will greatly help reduce the gap in the field where there is a lack of medical staff skilled in imaging diagnosis, allowing for high-quality medical services to be provided anywhere in the world,” said Yoo Kyu-tae, CEO of Samsung Medison. “By combining Samsung’s technological prowess with Sonio AI solutions, we will lead innovation in medical device accessibility and accuracy.”